BackNemaura Medical Overview

Nemaura Medical Total Current Liabilities

Latest total current liabilities for NMRD: $23M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$23.00M
↑ 73.94% YoYΔ $9.78M vs prior year quarter

Peer trimmed avg / median

Loading

Nemaura Medical Total Current Liabilities History

Loading

Nemaura Medical vs. peers: Total Current Liabilities Comparison

Loading

Nemaura Medical Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Nemaura Medical (NMRD) FAQ

The latest total current liabilities for NMRD is $23M as of December 2023. That compares with $13M in the prior-year period — up 73.9% year over year. Investors often review this figure alongside Nemaura Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, NMRD's total current liabilities moved from $13M to $23M — a 73.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nemaura Medical's operating scale or balance-sheet position.

A total current liabilities figure of $23M for NMRD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NMRD's total current liabilities ($23M), review year-over-year change from $13M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Nemaura Medical's total current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.